无锡鸣鹭医药科技有限公司

当前位置:首页 > 产品 > 生命科学 > 细胞生物学 > 细胞信号传导 >Pazopanib, 98%, a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively

Pazopanib, 98%, a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ, c-Kit, FGFR1, and c-Fms with IC50s of 10, 30, 47, 84, 74, 140 and 146 nM, respectively

帕唑帕尼

MW : 437.52 CAS : 444731-52-6 EC号 : 437.52

货号（SKU）

包装规格

库存

价格

数量

981527

咨询

现价: ¥1712.00

基础信息

MF

C21H23N7O2S
MW

437.52
Synonymity

GW-786034, 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide
MP

301-313
BP

658
FP

359
Density

1.3
SpecialRequirement

Freezer -20℃
Hazard

LNLT
RiskSign

Warning
HValue

H317 H361
PValue

P280 P302+P352 P308+P313 P333+P313